Sarapultsev Petr A, Sarapultsev Alexey P
Federal State Autonomous Educational Institution of Higher Professional Education, Ural Federal University named after the first President of Russia B. N. Yeltsin, Russia; Institute of Immunology and Physiology of the Ural Branch of the RAS, Russia.
Federal State Autonomous Educational Institution of Higher Professional Education, Ural Federal University named after the first President of Russia B. N. Yeltsin, Russia; Institute of Immunology and Physiology of the Ural Branch of the RAS, Russia.
Int J Cardiol. 2016 Oct 15;221:698-718. doi: 10.1016/j.ijcard.2016.07.030. Epub 2016 Jul 5.
In 2006, Takotsubo syndrome (TTC) was described as a distinct type of stress-induced cardiomyopathy (stress cardiomyopathy). However, when thinking about Takotsubo cardiomyopathy from the viewpoints of the AHA and ESC classifications, 2 possible problems may arise. The first potential problem is that a forecast of disease outcome is lacking in the ESC classification, whereas the AHA only states that 'outcome is favorable with appropriate medical therapy'. However, based on the literature data, one can make a general conclusion that occurrence of myocardial lesions in TTC (i.e., myocardial fibrosis and contraction-band necrosis) causes the same effects as in other diseases with similar levels of myocardial damage and should not be considered to have a lesser impact on mortality. To summarise, TTC can cause not only severe complications such as pulmonary oedema, cardiogenic shock, and dangerous ventricular arrhythmias, but also damage to the myocardium, which can result in the development of potentially fatal conditions even after the disappearance of LV apical ballooning. The second potential problem arises from the definition of TTC as a stress cardiomyopathy in the AHA classification. In fact, the main factors leading to TTC are stress and microvascular anginas, since, as has been already discussed, coronary spasm can cause myocardium stunning, resulting in persistent apical ballooning. Thus, based on this review, 3 distinct types of stress cardiomyopathies exist (variant angina, microvascular angina, and TTC), with poor prognosis. Adding these diseases to the classification of cardiomyopathies will facilitate diagnosis and preventive prolonged treatment, which should include intensive anti-stress therapy.
2006年,应激性心肌病(应激性心肌病)被描述为一种独特类型的应激性心肌病。然而,从美国心脏协会(AHA)和欧洲心脏病学会(ESC)分类的角度考虑应激性心肌病时,可能会出现两个问题。第一个潜在问题是ESC分类中缺乏疾病预后的预测,而AHA仅指出“适当的药物治疗预后良好”。然而,根据文献数据,可以得出一个普遍结论,即应激性心肌病中心肌病变(即心肌纤维化和收缩带坏死)的发生与其他心肌损伤程度相似的疾病具有相同的影响,不应被认为对死亡率的影响较小。总之,应激性心肌病不仅可导致肺水肿、心源性休克和危险的室性心律失常等严重并发症,还可导致心肌损伤,即使左心室心尖部气球样变消失后,也可导致潜在致命情况的发生。第二个潜在问题源于AHA分类中将应激性心肌病定义为应激性心肌病。事实上,导致应激性心肌病的主要因素是应激和微血管性心绞痛,因为如前所述,冠状动脉痉挛可导致心肌顿抑,导致持续性心尖部气球样变。因此,基于本综述,存在三种不同类型的应激性心肌病(变异型心绞痛、微血管性心绞痛和应激性心肌病),预后较差。将这些疾病纳入心肌病分类将有助于诊断和预防性长期治疗,其中应包括强化抗应激治疗。